Mycorena: Funding, Investors & Team (Sep 2026)
Our goal at Mycorena is to fundamentally alter how we produce and consume food. By providing the market with scalable, high-quality goods, we hope to open the door for a sustainability revolution and demonstrate the potential of fungus. We create sustainable mycelium-based solutions for the food industry using cutting-edge technology. Our main offering A vegan mycoprotein with greater nutritional value in terms of protein, fibre, vitamins, and minerals is called "Promyc." Promyc provides the most sought-after characteristics in the alternative protein market, offering a neutral flavour and a pleasant fibrous texture. What began as a study initiative has developed into one of the industry's fastest-growing businesses.
Mycorena has raised $26.7M across 2 funding rounds on record, the most recent an undisclosed round announced in Jan 2023.
Mycorena Company Profile and Key Stats
Latest funding round on record: Jan 2023.
Mycorena Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Mycorena raised $26.7M in a Series A announced in Mar 2022.
10 months later, an undisclosed round was announced in Jan 2023 with no disclosed amount.
Mycorena Founders and Leadership Team
No contact details are on record for this team yet.
Mycorena Funding Compared to Other Biotechnology Startups
Funded Startups Like Mycorena in Biotechnology and Gothenburg
Companies Similar to Mycorena
Pixelgen Technologies, established in Sweden in 2020, focuses on the advancement of biomedical research and…
Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic…
Emulsi Biotech is a biotechnology company that develops lipid technology to deliver biologic drugs orally.
Our vision is to develop and bring to the market safe and effective treatments for women specific diseases…
OncoZenge is a Swedish pharmaceutical company. It develops better products for the supportive care of cancer…
Elicera Therapeutics is a clinical stage immuno-oncology company developing cell and gene therapies for…
Alligator Bioscience is an innovative research based biotech company focused on developing novel drugs for…
Moleculent is dedicated to creating tech-based products that utilize fresh knowledge about the molecular…
Bio-Works was established in 2006 and specializes in creating, producing, and distributing cutting-edge…
Verigraft AB is a biotech company that creates personalized tissue-engineered transplants for use in…
Lipum aims to eliminate or alleviate painful symptoms for millions of patients suffering from chronic…
ArgusEye is a biotech firm that offers sensor solutions for instant identification of biological systems and…
Mycorena Funding FAQs
What does Mycorena do?
Our goal at Mycorena is to fundamentally alter how we produce and consume food. By providing the market with scalable, high-quality goods, we hope to open the door for a sustainability revolution and demonstrate the potential of fungus. We create sustainable mycelium-based solutions for the food industry using cutting-edge technology. Our main offering A vegan mycoprotein with greater nutritional value in terms of protein, fibre, vitamins, and minerals is called "Promyc." Promyc provides the most sought-after characteristics in the alternative protein market, offering a neutral flavour and a pleasant fibrous texture. What began as a study initiative has developed into one of the industry's fastest-growing businesses.
How much funding has Mycorena raised?
Mycorena has raised $26.7M across 2 rounds on record.
When did Mycorena last raise funding?
Mycorena's most recent funding round on record was announced in Jan 2023. The amount was not disclosed.
Who is the CEO of Mycorena?
Ramkumar Nair is listed as CEO at Mycorena.
Where is Mycorena headquartered?
Mycorena is based in Gothenburg, Vastra Gotaland, Sweden.
How many employees does Mycorena have?
Mycorena is in the 51-100 employee band.
About FundedIQ's Mycorena Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Mycorena is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.